ISSN 2639-9431
Vol. 8, Issue 4, 2025November 02, 2025 EDT
GIMAP and Lipid Metabolism Imaging in Clear Cell Renal Cell Carcinoma: A Negative Radiogenomic Analysis
GIMAP and Lipid Metabolism Imaging in Clear Cell Renal Cell Carcinoma: A Negative Radiogenomic Analysis
Federico Greco, M.D., Marco Cataldo, Eng.D., Andrea Panunzio, M.D., Alessandro Tafuri, M.D., Ph.D., Bruno Beomonte Zobel, M.D., Full Professor, Carlo Augusto Mallio, M.D., Ph.D., Associate Professor,
Articles in Vol. 8, Issue 4, 2025
Vol. 8, Issue 4, 2025
- Development and Characterization of Bromocriptine Mesylate Loaded Nanostructured Lipid Carriers for Enhanced Nose-to-Brain DeliveryDarshan KAAnita R DesaiMallappa ShalavadiBasavaraj S. NainegaliLaxman S Vijapur
- GIMAP and Lipid Metabolism Imaging in Clear Cell Renal Cell Carcinoma: A Negative Radiogenomic AnalysisFederico GrecoMarco CataldoAndrea PanunzioAlessandro TafuriBruno Beomonte ZobelCarlo Augusto Mallio
- A Validated Serum Biomarker Signature for the Non-Invasive Diagnosis of EndometriosisRusul F. AbediAhmed Jasim MohammedAbbas ChyadRedha Dawud Abd AlredhaGhanim A. AbbasKrarr Haider Haddawi
- Comparing CRISPR-Cas9 Gene Therapy Delivery Systems: Implications and Optimization for HyperargininemiaJad MadaniHumza N. ZubairGhazi A. SaroyaRachel E.N. ReyesRami Madani
- From BioMAG® to Feraheme®: Overview of the Intellectual Property HistoryErnest GromanDmitri Simberg
Greco, Federico, Marco Cataldo, Andrea Panunzio, Alessandro Tafuri, Bruno Beomonte Zobel, and Carlo Augusto Mallio. 2025. “GIMAP and Lipid Metabolism Imaging in Clear Cell Renal Cell Carcinoma: A Negative Radiogenomic Analysis.” Precision Nanomedicine 8 (4): 1600–1610. https://doi.org/10.33218/001c.146452.